SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-290130
Filing Date
2020-11-10
Accepted
2020-11-10 16:01:19
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d37881d10q.htm 10-Q 396245
2 EX-31.1 d37881dex311.htm EX-31.1 10574
3 EX-31.2 d37881dex312.htm EX-31.2 10588
4 EX-32.1 d37881dex321.htm EX-32.1 5433
11 GRAPHIC g37881dsp23a.jpg GRAPHIC 12288
12 GRAPHIC g37881dsp23b.jpg GRAPHIC 17820
13 GRAPHIC g37881g23j60.jpg GRAPHIC 120666
  Complete submission text file 0001193125-20-290130.txt   3933131

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20200930.xml EX-101.INS 758396
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20200930.xsd EX-101.SCH 38167
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20200930_cal.xml EX-101.CAL 31192
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20200930_def.xml EX-101.DEF 258752
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20200930_lab.xml EX-101.LAB 333447
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20200930_pre.xml EX-101.PRE 294380
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 201301046
SIC: 2834 Pharmaceutical Preparations